SFAF.org Podcast #62 - New HIV Vaccine Trial Begins

One of the least understood areas of HIV research is the ongoing hunt for a vaccine to prevent infection. In this episode, Jen Sarché of the San Francisco Department of Public Health, answers questions about the 505 Study, a new HIV vaccine trial being conducted by the HIV Vaccine Trials Network at the National Institutes of Health. San Francisco is one of ten nationwide sites for the 505 Study, designed to increase our understanding of the T-cell's response to infection. Jen will work with partners across the region—including the San Francisco AIDS Foundation—to raise understanding about HIV vaccines and how individuals can get involved in the search.

SFAF.org Podcast #55 - The intersection of biomedical HIV prevention and social justice

In this episode, we'll hear an edited excerpt from our recent HIVision forum entitled “Is HIV Treatment HIV Prevention?” An audience member asked our panel about possible disparities in access to Pre-Exposure Prophylaxis (PrEP). We'll hear Dr. Robert Grant's answer explaining the relationship between biomedical HIV prevention and issues of social justice and stigma.

SFAF.org Podcast #52 - HIV meds for HIV prevention? Dr. Bob Grant discusses global PrEP studies.

In this episode, Dr. Bob Grant, Associate Professor of Medicine at UCSF and an investigator at the Gladstone Institute of Virology and Immunology, discusses the PrEP Initiative study. These trials are trying to determine whether HIV medications given to HIV negative people at higher risk of infection will help reduce the amount new infections.

SFAF.org Podcast #39 - Magnet finds acute HIV infection with RNA testing

In this episode, Tim Ryan, a registered nurse and the clinical services manager at Magnet, the Foundation's gay men's sexual health clinic, talks about what Magnet's doing differently to encourage sexual health in San Francisco's gay male community and why RNA testing for HIV may reduce HIV infection rates with early diagnosis of acute HIV infection. Recent studies suggest that acute HIV infection may be responsible for up to 50% of new HIV infections in San Francisco.

SFAF.org IAC Podcast - Mark Cloutier outlines the significance of the CDC's recently revised HIV numbers

The Centers for Disease Control released its long-awaited revision of HIV incidence in the United States as the XVII International AIDS Conference got underway in Mexico City. In this special Conference edition of the SFAF.org podcast, Foundation CEO Mark Cloutier explains the new data and the ways in which San Francisco may be bucking the national trend. 

SFAF.org Podcast #34 - Tom Kennedy on the current state of HIV vaccine trials

In this episode, Tom Kennedy, a public health educator who has been working in HIV prevention in San Francisco since 1992, discusses the current state of HIV vaccine trials. Last autumn, the STEP HIV vaccine trial was halted due to safety concerns. With delays now affecting the launch of new vaccine trials, Tom answers questions about the state of HIV vaccine research and what is being done to ensure the safety of trial participants.

SFAF.org Podcast #32 - Ernest Hopkins on government response to the rising HIV transmission rate among Black MSM

In this episode, Ernest Hopkins, the Foundation's Director of Federal Affairs, discusses the local and federal response to rising HIV transmission rates among Black men who have sex with men. Ernest Hopkins will be a panelist at our May 15th HIVision Forum entitled What's Going On: HIV and Black Gay Men.

SFAF Podcast #23 - The Year in Review with Mark Cloutier

In this episode, Mark Cloutier, Executive Director of the San Francisco AIDS Foundation and President of Pangaea Global AIDS Foundation, discusses a year of lessons learned in the fight against HIV and opportunities that lie ahead in 2008 to review and revise approaches to prevention and care, and improve popular understanding of HIV and AIDS.

SFAF Podcast #22 - Dr. Judith Auerbach Challenges the Definition of Evidence-Based HIV Prevention

In this episode Dr. Judith Auerbach, Deputy Executive Director for Science and Public Policy at the San Francisco AIDS Foundation talks defining the meaning of evidence in relation to evidence-based HIV prevention.

SFAF Podcast #15 - New HIV Drug Classes and Treatment Recommendations

Just back from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Sydney, BETA editor Reilly O'Neal gives us an update on two new HIV drug classes and a new early treatment recommendation. At the Sydney Conference, Reilly joined experts and advocates from around the globe for a look at the cutting edge of HIV drug and treatment information.